-+ 0.00%
-+ 0.00%
-+ 0.00%

Sanofi: The US FDA has previously granted Efdoralprin Alfa Fast Track and Orphan Drug certification.

Zhitongcaijing·12/17/2025 06:09:00
Listen to the news
Sanofi: The US FDA has previously granted Efdoralprin Alfa Fast Track and Orphan Drug certification.